Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 8/20 | 0.62 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.62 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.62 |
| ▸ | PGR | P06401 | 1/20 | 0.62 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.62 |
| ▸ | PDE4A | P27815 | 1/20 | 0.62 |
| ▸ | BLVRB | P30043 | 1/20 | 0.62 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.62 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.62 |
| ▸ | PPID | Q08752 | 1/20 | 0.57 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.42 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23956926 | 0.87 | XDH (0.67) | XDHABCC4ABCB11PGRCHRM1 | |
| Hydrochloric Acid SCHEMBL29217415 | 0.87 | XDH (0.60) | XDHABCC4ABCB11PGRCHRM1 | |
| Hydrochloric Acid SCHEMBL29217526 | 0.86 | XDH (0.66) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL23956992 | 0.86 | XDH (0.66) | XDHABCC4ABCB11PGRCHRM1 | |
| Hydrochloric Acid SCHEMBL29217531 | 0.86 | XDH (0.61) | XDHABCC4ABCB11PGRCHRM1 | |
| Hydrochloric Acid SCHEMBL29217429 | 0.86 | XDH (0.61) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL25828265 | 0.86 | XDH (0.61) | XDHABCC4ABCB11PGRCHRM1 | |
| Hydrochloric Acid SCHEMBL29217422 | 0.85 | XDH (0.65) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL25828204 | 0.84 | XDH (0.67) | XDHABCC4ABCB11PGRCHRM1 | |
| SCHEMBL23956940 | 0.83 | XDH (0.64) | XDHABCC4ABCB11PGRCHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219908-A1 | NOVEL 2-ARYLTHIAZOLE DERIVATIVE OR SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | HEXAPHARMATEC CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219908-A1 | NOVEL 2-ARYLTHIAZOLE DERIVATIVE OR SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | WEE2, WEE1, NOTUM | XDH 1995/4885ABCC4 1104/4885ABCB11 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.